Danny founded, co-founded, or seed-funded a dozen start-ups that have raised over $1 billion from venture capital and strategic investors, including Mainstay Medical, Respicardia (acquired), Neuronetics (STIM), Amphora Medical, and CoTherix (acquired).
He has led the Innovation Fellows Program since 2020. He previously was a venture investor with Investor Growth Capital and Spray Venture Partners, and Instructor in Medicine at Harvard Medical School.
Danny earned BA and MD degrees from The University of Michigan, Board Certification from the American Board of Emergency Medicine, and an MBA from Harvard Business School.